REQUEST A DEMO
Total
USD $0.00
Search more companies

Swixx Biopharma S.R.O. (Czech Republic)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Swixx Biopharma S.R.O. Profile Updated: November 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Swixx Biopharma S.R.O. is an enterprise in Czech Republic, with the main office in Prague. The enterprise operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. It was established on June 08, 2017. It currently has a total number of 25 - 49 (2023) employees. The company’s latest financial report indicates a net sales revenue increase of 7.14% in 2022. During that time, Swixx Biopharma S.R.O.’s total assets decreased by 47.03%. The enterprise’s net profit margin increased by 0.16% in 2022.

Headquarters
Hybernska 1034/5
Prague; The City of Prague; Postal Code: 11000

Contact Details: Purchase the Swixx Biopharma S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Swixx Biopharma S.R.O. report to view the information.
Outstanding Shares:
Purchase the Swixx Biopharma S.R.O. report to view the information.
Registered Capital:
Purchase the Swixx Biopharma S.R.O. report to view the information.
Incorporation Date:
June 08, 2017
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Swixx Biopharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
7.14%
Total operating revenue
7.17%
Operating profit (EBIT)
8.16%
EBITDA
7.03%
Net Profit (Loss) for the Period
14.26%
Total assets
-47.03%
Total equity
51.39%
Operating Profit Margin (ROS)
0.03%
Net Profit Margin
0.16%
Return on Equity (ROE)
-11.03%
Debt to Equity Ratio
-10.13%
Quick Ratio
0.51%
Cash Ratio
0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?